Cited 3 times in
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.